Results 91 to 100 of about 14,755 (179)

Silibinin suppresses glioblastoma cell growth, invasion, stemness, and glutamine metabolism by YY1/SLC1A5 pathway

open access: yesTranslational Neuroscience
Silibinin has been found to inhibit glioblastoma (GBM) progression. However, the underlying molecular mechanism by which Silibinin regulates GBM process remains unclear.
Liu Ming   +3 more
doaj   +1 more source

YY1: a key regulator inhibits gastric cancer ferroptosis and mediating apatinib-resistance

open access: yesCancer Cell International
Objective Gastric cancer (GC) stands as a prevalent and deadly global malignancy. Despite its role as a preoperative neoadjuvant therapy, Apatinib’s effectiveness is curtailed among GC patients exhibiting elevated YY1 expression.
Zi-Han Geng   +6 more
doaj   +1 more source

Characterization of the Transcriptional Regulator YY1 [PDF]

open access: yesJournal of Biological Chemistry, 1997
Matthias Austen   +2 more
openaire   +1 more source

YY1 Suppresses Tumor Growth by Negatively Regulating the Expression and Translation Activity of eIF4E in Nasopharyngeal Carcinoma. [PDF]

open access: yesCancers (Basel)
Duan Y   +11 more
europepmc   +1 more source

m<sup>6</sup>A mRNA methylation regulates pancreatic α-cell plasticity. [PDF]

open access: yesNat Metab
De Jesus DF   +14 more
europepmc   +1 more source

Synthesis and Hepatotoxicity Evaluation of Paeonol Clofibrate. [PDF]

open access: yesChem Biodivers
Tu H   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy